All News

I frequently relive the day I was diagnosed with cancer and realized that I may need to limit my exposure to other people’s cancer battles.

Cosela tended to decrease myelosuppressive events — when the bone marrow is not working sufficiently to produce blood cells and platelets — in patients receiving chemotherapy for extensive-stage small cell lung cancer.

Beyond its lessons, cancer has also brought, along with the fear and anxiety, a conviction to empower myself and to create a life that I deserve: One in which joy can triumph over that fear and that anxiety.

Watch Dr. Jedd D. Wolchok, Lorenzo Cohen, Dr. Anna C. Pavlick and Julie Bain answer questions about treating skin cancer, during the CURE Educated Patient Skin Cancer Summit.

As I enter my second year of grief and the shock and fog of the traumatic loss of my wife to cancer has waned a bit, sometimes I see things a little clearer. And one thing I do know, there was something that I did get right.

Watch Dr. Anna C. Pavlick, from Weill Cornell Medicine, discuss clinical trials during the CURE Educated Patient Skin Cancer Summit.

The first patient enrolled onto a phase 1 trial has received TCMB07, an investigational drug, for the treatment of cachexia, a severe disorder that may occur in more than half of patients with advanced-stage cancer.

If I make a wrong turn while hiking, I backtrack until I find my way again. I’ve decided that it’s OK to do the same thing when it comes to finding a cancer care team.

The safety, optimal dosage and efficacy of the investigational drug is currently being evaluated in a first-in-human trial in patients with recurrent high-grade glioblastoma, a type of spinal cord and brain cancer.

The FDA has permitted the manufacturer of a novel drug to continue a phase 3 clinical trial investigating the effects of treatment with a novel drug in patients with HER2/neu-positive primary breast cancer.

Treatment with Cabometyx in combination with Tecentriq induced superior progression-free survival outcomes and disease control rates versus Nexavar alone in patients with advanced hepatocellular carcinoma, the most common type of liver cancer.

The decision to be treated locally or at a large research center can be a difficult one, but I am lucky enough to have both.

Amazon and Fred Hutchinson Cancer Center recently launched an early-phase clinical trial to assess the safety and efficacy of a cancer vaccine in the treatment of patients with late-stage skin cancer or hormone receptor-positive, HER2-negative breast cancer.

Watch Dr. Jedd D. Wolchok, from Memorial Sloan Kettering Cancer Center, discuss immunotherapy, during the CURE Educated Patient Skin Cancer Summit.

The manufacturer of one of the cancer treatments announced that it is also participating in clinical trials assessing the safety and efficacy of their product in colorectal and endometrial cancer.

When a friend with metastatic breast cancer said that her cancer responded to treatment and she was excited to stop taking daily pills, I thought that something must have been miscommunicated to her.

The use of a chemotherapy-free, combination regimen as a maintenance treatment option was associated with an improvement in survival in a group of patients with advanced pancreatic cancer.

Watch Dr. Sherrif Ibrahim, Dr. Erica B. Friedman and Dr. Nicholas Sanfilippo answer questions about the multidisciplinary approach to care during the CURE Educated Patient Skin Cancer Summit.

The manufacturer of the novel CAR-T cell therapy announced it terminated an early-phase trial investigating the treatment’s efficacy after there was a lack of benefit in patients with relapsed or refractory T-cell lymphoma, a type of blood cancer.

A clinical trial reviewing the safety and efficacy of a treatment regimen of enoblituzumab in combination with either retifanlimab or tebotelimab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck has been stopped by the manufacturer of the cancer drugs.

After cancer, my “normal” life is long forgotten, but how can I get back to life as a person who is well?

Heartbreak and loss trail behind us every day in the cancer world. But so does understanding, friendship and love.

Watch Dr. Nicholas Sanfilippo, from Weill Cornell Medicine, discuss radiation therapy options during the CURE Educated Patient Skin Cancer Summit.

The FDA granted abelacimab a fast track designation for the treatment of thrombosis, a common and sometimes deadly type of blood clot associated with cancer.

The first patient was dosed in a phase 2 trial studying the efficacy of sapanisertib in patients with NRF2-mutant relapsed/refractory lung cancer.

After being diagnosed with cancer, I took a hard look at what I was eating and made some positive changes.

Thanks to the FDA approval of immunotherapy agents, the average survival for patients for stage 4 melanoma has drastically increased over the past 20 years, an expert explained.

Watch Dr. Erica B. Friedman, from NYU Grossman School of Medicine, discuss surgery, during the CURE Educated Patient Skin Cancer Summit.